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Abstract
Background: Degenerative musculoskeletal disorders are among the most frequent diseases occurring in
adulthood, often impairing patients’ functional mobility and physical activity. The aim of the present study was to
investigate and compare the impact of three frequent degenerative musculoskeletal disorders – knee osteoarthritis
(knee OA), hip osteoarthritis (hip OA) and lumbar spinal stenosis (LSS) – on patients’ walking ability.
Methods: The study included 120 participants, with 30 in each patient group and 30 healthy control individuals.
A uniaxial accelerometer, the StepWatch™ Activity Monitor (Orthocare Innovations, Seattle, Washington, USA), was
used to determine the volume (number of gait cycles per day) and intensity (gait cycles per minute) of walking
ability. Non-parametric testing was used for all statistical analyses.
Results: Both the volume and the intensity of walking ability were significantly lower among the patients in
comparison with the healthy control individuals (p < 0.001). Patients with LSS spent 0.4 (IQR 2.8) min/day doing
moderately intense walking (>50 gait cycles/min), which was significantly lower in comparison with patients with
knee and hip OA at 2.5 (IQR 4.4) and 3.4 (IQR 16.1) min/day, respectively (p < 0.001). No correlations between
demographic or anthropometric data and walking ability were found. No technical problems or measuring errors
occurred with any of the measurements.
Conclusions: Patients with degenerative musculoskeletal disorders suffer limitations in their walking ability.
Objective assessment of walking ability appeared to be an easy and feasible tool for measuring such limitations as
it provides baseline data and objective information that are more precise than the patients’ own subjective
estimates. In everyday practice, objective activity assessment can provide feedback for clinicians regarding patients’
performance during everyday life and the extent to which this confirms the results of clinical investigations. The
method can also be used as a way of encouraging patients to develop a more active lifestyle.
Background
Degenerative musculoskeletal disorders are among the
most common diseases in adulthood and account for a
high percentage of cases of in-patient treatments, tem-
porary disability, inability to work and early retirement
[1,2]. The prevalence of degenerative diseases increases
with age, and current demographic changes are likely to
exacerbate the associated problems for modern societies.
A tt h es a m et i m e ,e l d e r l yp e o p l en o w a d a y sh a v eh i g h
standards in relation to their mobility, independence,
quality of life and ability to take part in social life. The
ability to walk is considered to be essential for most
activities of daily living [3].
In the field of orthopedics the most common and
most frequent conditions leading to major restrictions
of walking ability in patients over the age of 55 years
are osteoarthritis of the hip and knee and spinal claudi-
cation due to lumbar spinal stenosis associated with
osteoarthritis of the zygapophyseal joints [4]. A major
proportion of orthopedic surgeries are carried out in
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any medium, provided the original work is properly cited.these patients in order to restore mobility [5]. Typical
signs of OA are pain, joint stiffness and reduced walking
ability. The knee and the hip joints differ substantially
in their anatomical structure, ligamentous stabilization
and biomechanical characteristics. In addition, different
factors may lead to the development of OA in the two
joints. It is therefore relevant to investigate whether the
site of OA has an influence on patients’ walking ability.
Lumbar spinal stenosis (LSS) has an annual incidence of
about five per 100,000 population and is the most com-
m o nr e a s o nf o rs p i n a ls u r g e r y[ 6 ] .F r o mt h ep a t h o p h y -
siological point of view, LSS is similar to OA in the
peripheral joints as it results from bony hypertrophy of
osteoarthritic zygapophyseal joints, degenerative changes
and hypertrophy of the ligamenta flava and degeneration
of the intervertebral disc. In patients with LSS, pain is
caused by the compression of the nerve root leading to
neurogenic claudication as a cardinal symptom of the
condition. The pain radiates particularly into the back
and the legs and becomes more severe as the walking
distance increases. These symptoms are not typically
seen in patients with knee or hip OA. Despite the differ-
ent pathological mechanisms underlying the conditions,
limited mobility is the major symptom in all three
groups of patients.
T h ea i mo ft h ep r e s e n ts t u d yw a st ou s ea no b j e c t i v e
method to quantify and compare the impact of knee
OA, hip OA and LSS on patients’ walking ability. Objec-
tive measurements of the extent of disease-induced
restrictions in patients’ everyday life were carried out
and can be used as a basis for future studies, e.g., inter-
vention studies.
Subjective assessments of patients’ physical activity
using questionnaires or self-reporting have been found
to be inconsistent. Accelerometry, using devices worn
on the body that are able to detect the acceleration of
the body or parts of it in order to assess activity pat-
terns, has been shown to provide more accurate activity
measurements [7]. In contrast to laboratory situations,
in which only a snapshot of the patient’s walking ability
can be obtained [8] accelerometry provides information
about activities during daily life. Only objective data
during daily life were assessed in the present study. The
same device was used for all measurements, allowing
direct comparisons of the impact of various diseases on
walking ability.
The main research questions addressed in the present
study were:
￿ What is the extent of daily walking ability in nor-
mal everyday conditions for patients with the most
common degenerative orthopedic diseases?
￿ How do these data compare with a healthy cohort
of similar age and gender distribution?
￿ Are there any differences between patients suffer-
ing from degenerative disease of the spine, the hip
or the knee? Are there particularly severe limitations
affecting one of these groups?
￿ Does the measurement technique used represent a
practical tool for assessing patients with degenerative
musculoskeletal diseases?
Methods
Patients
The study included 120 participants, 30 patients each
with knee OA, hip OA and LSS and 30 healthy control
individuals with a comparable age and gender distribu-
tion (Table 1). All of the patients had radiographic and
clinical signs that were pathognomonic for their dis-
eases. In patients with OA the grade of OA was 3 or
higher according to the Kellgren-Lawrence system.
Patients with LSS also had high disease grades. All of
the patients were suffering from severe symptoms for
which conservative treatment had failed, and they were
all scheduled for either primary endoprosthetic joint
replacement or decompressive spinal surgery. The deci-
sion to carry out surgery had been made by experienced
orthopedic surgeons, totally independent from this
investigation. The control individuals had no history of
musculoskeletal disorders and reported no knee, hip, or
back pain and no walking restrictions. Exclusion criteria
for all participants consisted of peripheral arterial dis-
eases, rheumatic diseases, systemic muscular diseases,
fractures in the lower extremities and cardiac, pulmon-
ary and circulatory diseases severely affecting the
patients’ mobility. Informed written consent to partici-
pate in the investigation was obtained from all of the
participants. The study was approved by the Ethics
Committee at Muenster University and was conducted
in accordance with the Helsinki Declaration of 1975,
revised in 1983.
A total of 128 individuals were invited to participate
in the study. Seven patients did not agree to participate,
and the data for one patient could not be evaluated as
the measurement period was too short. Reasons given
for non-participation were either that the patients had
no interest in the study or that they expected unfavor-
able results as their walking was severely restricted. Four
patients with LSS, two patients with knee OA and one
patient with hip OA did not agree to participate.
Assessment of Walking Ability
Walking ability before surgery was investigated on seven
consecutive days. The number of gait cycles (one gait
cycle consists of two steps) was determined with the
StepWatch 3™ Activity Monitor (SAM; Orthocare Inno-
vations, Seattle, WA, USA). The device is a small (7.5 ×
5 × 2 cm), light-weight (43 g), uniaxial accelerometer. It
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Page 2 of 7is attached to the ankle with an elastic strap and is
unobtrusive for the user. An internal clock records
information about timing and bouts of activities.
The monitor has been validated in several studies and
has been reported to have a 99% accuracy rate in detect-
ing gait cycles per time interval [9,10]. Before being
attached to start data collection, the unit was pro-
grammed to adjust for the patient’s individual height,
walking speed (slow, normal, fast) and range of walking
speeds. It is not possible to manipulate the device, e.g.,
by shaking or moving without any actual walking activ-
ity. The SAM monitors and saves data over several
weeks and operates without providing the user with any
feedback, thereby minimizing test bias. It was pro-
grammed to store data at intervals of one minute; there-
fore, data was available for every minute of the
o b s e r v a t i o np e r i o d .T h ev o l u m ea n dt h ei n t e n s i t yo f
activity were assessed. Volume was defined as the total
number of gait cycles per day or per hour. To take the
potential influence of different wearing times into
account, gait cycles were also evaluated per hour of the
time the device was actually worn. Intensity of activity
was defined by the number of gait cycles per minute.
Moderately-intense aerobic physical activity is part of
accepted recommendations for a healthy lifestyle [11].
Translated into walking, this level was achieved by per-
forming at least 100 steps per minute [12] or 50 gait
cycles per minute. Continuous brisk walking was
required in order to achieve this level of activity [11].
The results are given as both the percentage of overall
activity spent at the moderate level and as the number
of minutes spent at this level.
The device was worn during waking hours with the
wearing periods also being documented in a daily log
list. Measurements were carried out 35.3 ± 5.2 days
before surgery. The participants wore the SAM for a
mean of 6.5 ± 0.8 days (min. 5 days, max. 10 days). The
average daily wearing time was 13.8 ± 1.5 hours (min.
10.1 hours, max. 17.1 hours).
During the week SAM monitoring was being carried
out pain was additionally assessed by having the patients
rate it on the following scale as used in the Short Form
36 questionnaire: no pain, very little pain, little pain,
moderate pain, severe pain, unbearable pain.
Data Analysis
On the assumption that 2000 gait cycles per day would
represent a clinically relevant difference with a standard
deviation of 2000 gait cycles per day, power calculation
showed that 27 patients would have to be recruited for
a substantial effect (d = 1) to be observed with a =
0.008 (after Bonferroni correction) and b = 0.80. Allow-
ing for possible drop-outs, it was decided to include 120
individuals with 30 in each group.
Descriptive statistics were calculated to compare the
demographic and anthropometric data, as well as the activ-
ity behavior of the sample populations. The Kolmogorov-
Smirnov test was used to test for normal distribution. Data
did not fulfill requirements for parametric testing; there-
fore, differences between groups were assessed with the
Kruskal-Wallis H-test and the Mann-Whitney U-test. All
results are given as medians and interquartile ranges (IQR).
The level of statistical significance was set at p < 0.008
after Bonferroni correction for multiple post-hoc pair-wise
comparisons. Spearman correlation coefficients were deter-
mined. The Statistical Package for the Social Sciences
(SPSS, version 15.0) was used for all statistical analyses.
Results
Hourly gait cycles were highly correlated with the gait
cycles per day (r = 0.95, p < 0.01). Therefore, the analy-
sis of gait cycles per hour did not provide any further
information and the volume of activity will be reported
as gait cycles per day only. The volume of activity
(assessed as gait cycles per day) was significantly lower
in all of the patients in comparison with the healthy
control group (p < 0.001; Table 2, Figure 1). Patients
with knee OA reached 76.4% of the control groups’
median values, patients with hip OA 65.3% and patients
with LSS 58.2%. There were no statistically significant
differences between the patient groups.
The number of minutes spent above 50 gait cycles per
minute and the percentage spent at this level of activity
were significantly lower in all three patient groups
Table 1 Anthropometric and demographic data for the patients and control group
Knee OA (n = 30) MD, IQR Hip OA (n = 30) MD, IQR LSS (n = 30) MD, IQR CON (n = 30) MD, IQR p-values
Age (y) 63.2 , 5.1 61.0, 20.0 66.3, 7.7 63.5, 9.8 0.35
Height (m) 1.67, 0.10 1.69, 0.15 1.73, 0.12 1.70, 0.13 0.16
Weight (kg) 82.0, 19.5 78.0, 21.0 90.0, 17.0 75.0, 14.8 0.08
BMI (kg/m
2) 29.8, 5.9 26.0, 3.8 28.1, 4.5 25.9, 3.6 0.27
Overweight (BMI > 25; n) 12 10 15 13
Obese (BMI > 30; n) 13 2 10 4
female/male 15/15 16/14 12/18 15/15
LSS = Lumbar Spinal Stenosis, CON = Control group, MD = Median, IQR = Inter Quartile Range
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Page 3 of 7compared to healthy subjects (p < 0.001; Table 2). Patients
with LSS spent significantly less time performing moderate
physical activity and the percentage of activity spent at this
level was significantly less compared to both patient
groups with OA (Table 2). No significant differences were
detected between patients with hip or knee OA.
None of the patients reported any problems in using
the device or restrictions resulting from the measure-
ment. None of the patients canceled the measurement,
one patient applied the device too late and measurement
duration was too short. Data for all the other patients
were evaluable and were used for analysis.
There were no significant differences between the
groups with regard to pain which did not correlate with
the activity data. Furthermore, neither high nor signifi-
cant correlations between step activity data and anthro-
pometric data, i.e. age, height, weight and body mass
index (BMI) could be detected (Table 3).
Discussion
Patients with degenerative orthopaedic diseases were
found to have considerable reductions in the volume
and the intensity of walking ability in comparison to
healthy control individuals of comparable age. With
Table 2 Data for walking ability in patients and controls
Knee OA
(n = 30)
MD, IQR
p-value vs
CON
Hip OA
(n = 30)
MD, IQR
p-value
vs. CON
LSS
(n = 30)
MD, IQR
p-value
vs CON
CON
(n = 30)
MD, IQR
p-value knee-
hip
p-value knee-
LSS
p-value hip-
LSS
GC/day 4675,
2575
0.001 3994,
2640
0.001 3564,
1839
0.001 6119,
2234
0.67 0.03 0.112
GC/hour 405, 206 0.007 317, 211 0.004 271, 150 0.001 450, 157 0.575 0.02 0.127
High Int.
(%)
0.8, 1.6 0.001 1.0, 4.9 0.001 0.1, 1.0 0.001 3.5, 4.1 0.450 0.007 0.005
Min > 50 2.5, 4.4 0.001 3.4, 16.1 0.006 0.4, 2.8 0.001 15.8, 15.6 0.670 0.005 0.003
GC = Gait cycles, Int = Intensity, LSS = Lumbar Spinal Stenosis, CON = Control group, MD = Median, IQR = Inter Quartile Range,
Min > 50 = minutes per day spend above 50 gait cycles per minute
Figure 1 Gait cycles per day of patients and control group OAK = Knee osteoarthritis, OAH = Hip osteoarthritis, LSS = Lumbar Spinal
Stenosis, CON = Control group, o outlier
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Page 4 of 7regard to the volume and intensity of activity patients
with knee and hip OA were comparable with one
another. While patients with knee OA had a slightly
greater volume of activity, patients with hip OA were
found to spend slightly more time on moderately
intense walking. However, the differences were minor
and not significant and did not appear to be clinically
relevant. Possible influences of anatomical and biome-
chanical differences between the knee and the hip joints
and of different disease mechanisms were not evident in
the patients studied and were not subject of the study.
Patients with LSS were found to have the greatest
restrictions in their walking ability, particularly in rela-
tion to moderately intense walking. These differences
suggest that disease-specific symptoms of LSS, resulting
from nerve compression and leading to spinal claudica-
tion, limit patients’ ability to walk to a greater extent
than the symptoms of knee or hip OA do. All of the
patients were scheduled to undergo appropriate sur-
geries as conservative treatment strategies had not led
to sufficient improvement in their symptoms. The
patients’ subjective perception of the risk associated
with the surgical interventions might have contributed
to some of the observed differences. Endoprosthetic
joint replacement is nowadays a generally-accepted sur-
gical procedure that is not especially feared by patients.
However, it is possible that spinal surgery may be
regarded with more skepticism due to fear of adverse
consequences. Patients with LSS may therefore wait
longer and present with more severe restrictions before
agreeing to undergo surgery - although the intensity of
pain did not differ between groups and did not correlate
with activity data. Assessment is particularly valuable in
patients with LSS, to allow objective quantification of
the actual extent of restrictions and to address this topic
with the patient. These patients may need special atten-
tion in order to encourage walking and physical activity
before and after surgery.
Generally recognized risk factors for degenerative
musculoskeletal diseases, i.e., advanced age and a high
BMI were also present in the patients included in the
present study [2,13-16]. However, there were no
significant differences either with regard to age or BMI
and no correlations between these factors and the
patients’ activity data were observed.
The device used in the present study appeared to be
an easily applicable tool for measuring walking ability in
patients with degenerative musculoskeletal disorders.
Adherence to measurement process was very good as
the wearing times recorded by the SAM were confirmed
by the times noted in the log-list. In addition, the mini-
mum wear time was five days per week. Only seven
patients (four with LSS) did not agree to participate. All
participating patients accepted the device and no appli-
cation errors or malfunctions were observed. The results
t h e r e f o r ew e r eu n l i k e l yt oh a v eb e e na f f e c t e db ya n y
adherence problems.
The technique used here can be recommended for
further research on mobility in patients suffering from
orthopedic problems. Impaired mobility is also a com-
mon symptom in non-orthopedic diseases, e.g. vascular
claudication and neurological disorders and the techni-
que could also be used in those fields. Practical applica-
tions might include monitoring the rehabilitation
process of patients by carrying out repeated measure-
ments and comparing different time points, e.g., before
and after intervention. The technique could also be used
to compare different intervention strategies or as an
intervention in itself by encouraging the patients to
reach certain levels of activity. However, further research
will be required in order to assess the method’sp e r f o r -
mance characteristics before it is used in longitudinal
studies.
Co-morbid conditions are quite common in the age
group of the patients investigated in the study and
reflect the typical situation in many older patients. Most
co-morbidities were excluded in this study in order to
focus on the actual impact of OA or LSS. However, pos-
sible co-morbidities that were not explicitly excluded
might still have influenced the results. A different
approach might have involved co-morbidities as typical
confounding factors and adjusting the data to take their
effects into account. This would have provided more
detailed and more realistic information about these
patients but would have resulted in very small sub-
groups, creating statistical problems.
In daily clinical practice objective activity measure-
ments provide valuable additional information about
what patients are able to perform during everyday life
and in their own familiar surroundings. Performance
tests such as timed walking tests in patients with OA or
treadmill tests in patients with LSS, are well-established
and are frequently used in clinical practice. These tests
are conducted in laboratory settings and provide only a
snap-shots of the patient [8] to assess what the patient
Table 3 Spearman Correlation Coefficients for
anthropometric data and activity data (all patients)
age height weight BMI
GC/day 0.158 (n.s.) 0.205 (n.s.) 0.102 (n.s.) -0.069 (n.s.)
GC/hour 0.145 (n.s.) 0.102 (n.s.) 0.112 (n.s.) -0.045 (n.s.)
High INT 0.017(n.s.) -0.82 (n.s.) -0.43 (n.s.) 0.068 (n.s.)
Min > 50 0.087(n.s.) -0.73 (n.s.) -0.028 (n.s.) 0.039 (n.s.)
GC = Gait cycles, INT = Intensity, LSS = Lumbar Spinal Stenosis, CON =
Control group, SD = Standard deviation, Min > 50 = minutes spend above 50
gait cycles per minute
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patient actually does at home in real-life conditions.
Only one previous study has compared patients with
knee OA, hip OA and LSS: Three groups were evaluated
with self-reported quality of life and but did not reveal
any significant differences before surgery [17]. Activity
restrictions measured by accelerometry have been
reported in patients with early OA of the knee [18] and
in patients with low back pain [16]. These findings were
confirmed by the present study. However, direct com-
parisons of results of different studies are difficult due
to different measurement devices and different stages of
the diseases.
Most previous studies on activity in patients with OA
or LSS used self-reports to determine the level of activ-
ity. This approach is influenced by each individual’s own
perceptions and interpretations and can provide valuable
information when rating a patient’s state of well-being.
However, self-reports are considered as an insufficient
and imprecise approach for quantitative activity assess-
ments [19]. Most questionnaires do not assess low
intensity levels which are quite typical in patient popula-
tions [19]. In previous studies accelerometry has been
shown to be a good and valid method here [7]. Compar-
isons between a patient’s self-reported activity and
actual activity and correlations between actual activity
and self-reported well-being could be valuable. This
would provide information about whether or not a
patient’s perception is adequate. However, such compar-
isons were not the subject of the present study.
To the best of our knowledge, this is the first study
that has used a single measurement device to compare
the impact of different degenerative musculoskeletal dis-
eases with respect to walking ability. The study therefore
focused on providing descriptive information and base-
line data for normal conditions in everyday life.
Limitations of the present study were the rather inho-
mogeneous sample of patients in the different groups
and between the different groups, with respect to dis-
ease progression, age and anthropometric data. Further-
more, the exclusion of co-morbidities might have led to
a biased patient sample and allowed no conclusions
about the impact of confounders. Furthermore, no self-
reported data was assessed for a comparison with objec-
tive data.
Conclusions
The present study provides basic activity data for three
distinct groups of patients with degenerative musculos-
keletal diseases. Considerably limited walking ability was
revealed in patients with knee OA, hip OA and LSS.
Patients with LSS experienced the greatest restrictions,
probably due to more severe symptoms. No relevant
correlations between the anthropometric or demo-
graphic data and the activity data were observed.
The device used allowed objective assessment of walk-
ing ability and appeared to be an easy and feasible tool
for the determination of limitations. In everyday prac-
tice, objective activity assessment can provide feedback
for clinicians regarding patients’ performance during
everyday life and the extent to which this confirms
results of clinical investigations. The method can
furthermore be used as a tool to encourage patients
towards a more active lifestyle and to evaluate
interventions.
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